Massive medicare data dive tests new pneumonia shot for seniors
NCT ID NCT06782282
Summary
This study aims to see how well the Prevnar 20 vaccine works in real life to prevent serious lung infections and pneumonia in adults aged 65 and older. Researchers will analyze the anonymous health records of over 22 million people on Medicare, comparing those who got the vaccine to those who did not. No new vaccines are given as part of this study; it only reviews existing medical data collected over about two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMUNITY ACQUIRED PNEUMONIA (CAP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer United States
New York, New York, 10017, United States
Conditions
Explore the condition pages connected to this study.